SSO Statement on Diversity, Equity, and Inclusion
Release date: October 12, 2023.
The Society of Surgical Oncology (SSO) is committed to advancing diversity, equity, and inclusion (DEI). We believe that diversity is not only a reflection of the varied backgrounds, perspectives, and experiences of our members but also a vital driver of excellence in patient care, research, and education.
Read SSO’s full Statement on Diversity, Equity, and Inclusion here.
SSO 2024 Presidential Address
SSO President Kelly K. Hunt, MD, FSSO, delivers her SSO 2024 Presidential Address titled, “Empowering Surgeons: A Call for Leadership, Mentorship and Collaboration in the Field of Surgical Oncology.”
The Society of Surgical Oncology (SSO) leadership evaluates external organization’s endorsement opportunities to determine whether the document addresses a gap in surgical oncology, fosters quality care in surgical oncology and is a topic of interest to the SSO membership. An organization’s request must meet several criteria and the review process make take up to three months. For additional information and to complete an Endorsement Request Form please click here.
A Heritage of Leadership
Since our founding in 1940, SSO has championed leading-edge education, research, and quality impacting the full spectrum of surgical oncology and cancer care. Our members in 70 countries embrace the values that have enabled cancer surgeons to continually expand their knowledge, refine their decision-making skills and drive better outcomes for patients. The mission of the Society of Surgical Oncology is to improve multidisciplinary patient care by advancing the science, education and practice of cancer surgery worldwide. Today, SSO is a dynamic global community of cancer surgeons shaping advancements in the profession to deliver the highest quality surgical care for cancer patients.